European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation.
Autor: | Ali N; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Aktaa S; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Younsi T; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Beska B; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Batra G; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Blackman DJ; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., James S; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Ludman P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Mamas MA; Keele Cardiovascular Research Group, Keele University, Keele, UK., Abdel-Wahab M; Heart Center Leipzig, University of Leipzig, Leipzig, Germany., Borregaard B; Department of Cardiology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Iung B; Cardiology Department, Bichat Hospital, AP-HP, and Université Paris-Cité, Paris, France., Joner M; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany., Kunadian V; Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Modine T; Hôpital Cardiologique du Haut-Lévêque, Bordeaux, France., Neylon A; Saolta University Health Care Group, University Hospital Galway, and National University of Ireland, Galway, Ireland., Petronio AS; Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Pisa University Hospital, Pisa 56100, Italy., Pibarot P; Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec City, Québec, Canada., Popescu BA; University of Medicine and Pharmacy Carol Davila, Bucharest, Romania., Sabaté M; Interventional Cardiology Department, Cardiovascular Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain., Stortecky S; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Teles RC; CHLO, Nova Medical School, Hospital de Santa Cruz, CEDOC, Lisbon, Portugal., Treede H; Department of Cardiovascular Surgery, University Medical Center Mainz, Mainz, Germany., Gale CP; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.; Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2024 Dec 19; Vol. 10 (8), pp. 723-736. |
DOI: | 10.1093/ehjqcco/qcae006 |
Abstrakt: | Aims: To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing transcatheter aortic valve implantation (TAVI). Methods and Results: We followed the European Society of Cardiology (ESC) methodology for the development of QIs. Key domains were identified by constructing a conceptual framework for the delivery of TAVI care. A list of candidate QIs was developed by conducting a systematic review of the literature. A modified Delphi method was then used to select the final set of QIs. Finally, we mapped the QIs to the EuroHeart (European Unified Registries on Heart Care Evaluation and Randomized Trials) data standards for TAVI to ascertain the extent to which the EuroHeart TAVI registry captures information to calculate the QIs. We formed an international group of experts in quality improvement and TAVI, including representatives from the European Association of Percutaneous Cardiovascular Interventions, the European Association of Cardiovascular Imaging, and the Association of Cardiovascular Nursing and Allied Professions. In total, 27 QIs were selected across 8 domains of TAVI care, comprising 22 main (81%) and 5 secondary (19%) QIs. Of these, 19/27 (70%) are now being utilized in the EuroHeart TAVI registry. Conclusion: We present the 2023 ESC QIs for TAVI, developed using a standard methodology and in collaboration with ESC Associations. The EuroHeart TAVI registry allows calculation of the majority of the QIs, which may be used for benchmarking care and quality improvement initiatives. (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.) |
Databáze: | MEDLINE |
Externí odkaz: |